{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:26:44Z","timestamp":1786991204292,"version":"build-2736575974"},"reference-count":146,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.jaad.2010.12.049","type":"journal-article","created":{"date-parts":[[2012,5,12]],"date-time":"2012-05-12T02:43:32Z","timestamp":1336790612000},"page":"883.e1-883.e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Human papillomavirus\u2013related genital disease in the immunocompromised host"],"prefix":"10.1016","volume":"66","author":[{"given":"Rachel H.","family":"Gormley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie L.","family":"Kovarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.12.049_bib1","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0002-9378(95)90399-2","article-title":"Epidemiology and clinical pathophysiology of condylomata acuminata","volume":"172","author":"Ferenczy","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2010.12.049_bib2","first-page":"62","article-title":"Sexually transmitted diseases treatment guidelines, 2006","volume":"55","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jaad.2010.12.049_bib3","first-page":"5","article-title":"The diagnosis and treatment of human papillomavirus-mediated genital lesions","volume":"79","author":"Brodell","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2010.12.049_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1471-2334-9-119","article-title":"Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model","volume":"9","author":"Insinga","year":"2009","journal-title":"BMC Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.jaad.2010.12.049_bib5","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1086\/342109","article-title":"External genital warts: diagnosis, treatment, and prevention","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2010.12.049_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1258\/ijsa.2007.007290","article-title":"Treatment of anal human papillomavirus-associated disease: a long term outcome study","volume":"19","author":"Nathan","year":"2008","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib7","doi-asserted-by":"crossref","first-page":"233.e1","DOI":"10.1016\/j.ajog.2008.07.064","article-title":"Green tea catechins for treatment of external genital warts","volume":"200","author":"Meltzer","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaad.2010.12.049_bib8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1258\/0956462981921143","article-title":"An international survey of patients with genital warts: perceptions regarding treatment and impact on lifestyle","volume":"9","author":"Maw","year":"1998","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib9","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1177\/095646240401500508","article-title":"Patient assessment of anogenital warts and the success of treatment with home applied therapy","volume":"15","author":"Carey","year":"2004","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1086\/340743","article-title":"Validity of self-reporting of episodes of external genital warts","volume":"35","author":"Wiley","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"10.1016\/j.jaad.2010.12.049_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2133.2007.08274.x","article-title":"Evaluation of imiquimod for the therapy of external genital and anal warts in comparison with destructive therapies","volume":"157","author":"Schofer","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib12","first-page":"467","article-title":"Beyond a decade of 5% imiquimod topical therapy","volume":"8","author":"Gaspari","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus","volume":"134","author":"Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib14","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1128\/AAC.42.4.789","article-title":"Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts","volume":"42","author":"Beutner","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jaad.2010.12.049_bib15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1258\/095646204774195173","article-title":"Critical appraisal of commonly used treatment for genital warts","volume":"15","author":"Maw","year":"2004","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib16","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","article-title":"Treatment of genital warts with an immune-response modifier (imiquimod)","volume":"38","author":"Beutner","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib17","first-page":"453","article-title":"Diseases caused by human papillomaviruses (HPV)","volume":"7","author":"Handisurya","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2010.12.049_bib18","first-page":"74","article-title":"Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod","volume":"33","author":"Mashiah","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1258\/ijsa.2009.009154","article-title":"Imiquimod use in the genital area and development of lichen sclerosus and lichen planus","volume":"21","author":"O\u2019Mahony","year":"2010","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1440-0960.2004.00060.x","article-title":"Imiquimod: potential risk of an immunostimulant","volume":"45","author":"Benson","year":"2004","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jaad.2005.03.040","article-title":"Aphthous ulcers and imiquimod","volume":"53","author":"Zalaudek","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jaad.2004.06.045","article-title":"Aphthous ulcers associated with imiquimod and the treatment of actinic cheilitis","volume":"52","author":"Chakrabarty","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archderm.141.8.985","article-title":"Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial","volume":"141","author":"Brown","year":"2005","journal-title":"Arch Dermatol"},{"issue":"suppl 2","key":"10.1016\/j.jaad.2010.12.049_bib24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.2007.08269.x","article-title":"Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patients","volume":"157","author":"Ulrich","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0190-9622(99)70563-3","article-title":"An overview of sexually transmitted diseases","volume":"41","author":"Brown","year":"1999","journal-title":"Part II. J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib26","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1468-3083.2007.02169.x","article-title":"Human papillomavirus (HPV) viral load and HPV type in the clinical outcome of HIV-positive patients treated with imiquimod for anogenital warts and anal intraepithelial neoplasia","volume":"21","author":"Sanclemente","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.12.049_bib27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jcv.2007.04.001","article-title":"Effect of imiquimod in anogenital warts from HIV-positive men","volume":"39","author":"Herrera","year":"2007","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jaad.2010.12.049_bib28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archderm.134.1.33","article-title":"Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts","volume":"134","author":"Tyring","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib29","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0002-9343(94)90168-6","article-title":"Efficacy and safety of 0.5% podofilox solution in the treatment and suppression of anogenital warts","volume":"96","author":"Bonnez","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/09546639509086848","article-title":"Patient-applied treatment for genital warts: experience from a large postmarketing study","volume":"6","author":"Rosenberg","year":"1995","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaad.2010.12.049_bib31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00128071-200506040-00004","article-title":"Genital warts: current and future management options","volume":"6","author":"O\u2019Mahony","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/sti.77.6.409","article-title":"Podophyllin office therapy against condyloma should be abandoned","volume":"77","author":"von Krogh","year":"2001","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jaad.2010.12.049_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/sti.79.4.270","article-title":"Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts","volume":"79","author":"Lacey","year":"2003","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jaad.2010.12.049_bib34","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/rtph.2000.1446","article-title":"Condyloma eradication: self-therapy with 0.15-0.5% podophyllotoxin versus 20-25% podophyllin preparations\u2014an integrated safety assessment","volume":"33","author":"Longstaff","year":"2001","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jaad.2010.12.049_bib35","first-page":"387","article-title":"Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution","volume":"71","author":"Strand","year":"1995","journal-title":"Genitourin Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib36","first-page":"391","article-title":"A single-blind study of podophyllotoxin cream 0.5% and podophyllotoxin solution 0.5% in male patients with genital warts","volume":"71","author":"Petersen","year":"1995","journal-title":"Genitourin Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/095646249500600407","article-title":"Self-treatment of female external genital warts with 0.5% podophyllotoxin cream (Condyline) vs weekly applications of 20% podophyllin solution","volume":"6","author":"Hellberg","year":"1995","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/095646249400500405","article-title":"The cost effectiveness of treatment of genital warts with podophyllotoxin","volume":"5","author":"Mohanty","year":"1994","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib39","first-page":"735","article-title":"A double-blind, randomized trial of 0.5% podofilox and placebo for the treatment of genital warts in women","volume":"77","author":"Greenberg","year":"1991","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2010.12.049_bib40","first-page":"105","article-title":"Self-treatment using 0.25%-0.50% podophyllotoxin-ethanol solutions against penile condylomata acuminata: a placebo-controlled comparative study","volume":"70","author":"von Krogh","year":"1994","journal-title":"Genitourin Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib41","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(89)92282-4","article-title":"Patient-applied podofilox for treatment of genital warts","volume":"1","author":"Beutner","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2010.12.049_bib42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0002-9343(90)90424-C","article-title":"Double-blind randomized clinical trial of self-administered podofilox solution versus vehicle in the treatment of genital warts","volume":"88","author":"Kirby","year":"1990","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib43","first-page":"255","article-title":"Management of genital warts in women with human leukocyte interferon-alpha vs. podophyllotoxin in cream: a placebo-controlled, double-blind, comparative study","volume":"73","author":"Syed","year":"1995","journal-title":"J Mol Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00007435-198107000-00002","article-title":"Penile condylomata acuminata: an experimental model for evaluation of topical self-treatment with 0.5-1.0% ethanolic preparations of podophyllotoxin for three days","volume":"8","author":"von Krogh","year":"1981","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2010.12.049_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1258\/0956462961918400","article-title":"Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution","volume":"7","author":"Claesson","year":"1996","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib46","first-page":"5","article-title":"An evidence-based review of medical and surgical treatments of genital warts","volume":"12","author":"Scheinfeld","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2010.12.049_bib47","series-title":"Approval letter for Veregen\u2122 ointment, 15%. NDA 021902","year":"2006"},{"key":"10.1016\/j.jaad.2010.12.049_bib48","unstructured":"US Food and Drug Administration, Department of Health and Human Services web site. Veregen (kunecatechins) ointment, 15%. Available at: www.accessdata.fda.gov\/drugsatfda_docs\/label\/2006\/021902lbl.pdf. Accessed November 9, 2009."},{"key":"10.1016\/j.jaad.2010.12.049_bib49","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2133.2008.08520.x","article-title":"Topical polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial","volume":"158","author":"Stockfleth","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib50","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1111\/j.1468-3083.2007.02441.x","article-title":"A randomized, double-blind, four-arm parallel-group, placebo-controlled phase II\/III study to investigate the clinical efficacy of two galenic formulations of polyphenon E in the treatment of external genital warts","volume":"21","author":"Gross","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.12.049_bib51","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/AOG.0b013e3181719b60","article-title":"Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial","volume":"111","author":"Tatti","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2010.12.049_bib52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2133.2009.09375.x","article-title":"Polyphenon E: a new treatment for external anogenital warts","volume":"162","author":"Tatti","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib53","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jmv.1036","article-title":"Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir","volume":"64","author":"Koonsaeng","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaad.2010.12.049_bib54","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1432-2277.2006.00430.x","article-title":"Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients","volume":"20","author":"Bonatti","year":"2007","journal-title":"Transpl Int"},{"key":"10.1016\/j.jaad.2010.12.049_bib55","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3121\/cmr.4.4.273","article-title":"An armamentarium of wart treatments","volume":"4","author":"Lipke","year":"2006","journal-title":"Clin Med Res"},{"key":"10.1016\/j.jaad.2010.12.049_bib56","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0190-9622(97)70218-4","article-title":"The use of EMLA cream and 1% lidocaine infiltration in men for relief of pain associated with the removal of genital warts by cryotherapy","volume":"37","author":"Menter","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib57","first-page":"91","article-title":"Recurrence of condylomata acuminata following cryotherapy is not prevented by systemically administered interferon","volume":"69","author":"Eron","year":"1993","journal-title":"Genitourin Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib58","first-page":"16","article-title":"Treatment of external genital warts: a randomised clinical trial comparing podophyllin, cryotherapy, and electrodesiccation","volume":"66","author":"Stone","year":"1990","journal-title":"Genitourin Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib59","first-page":"390","article-title":"Cryotherapy compared with trichloroacetic acid in treating genital warts","volume":"63","author":"Godley","year":"1987","journal-title":"Genitourin Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib60","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00007435-199320060-00008","article-title":"Treatment of external genital warts comparing cryotherapy (liquid nitrogen) and trichloroacetic acid","volume":"20","author":"Abdullah","year":"1993","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2010.12.049_bib61","first-page":"297","article-title":"Subcutaneous interferon alpha 2a combined with cryotherapy vs cryotherapy alone in the treatment of primary anogenital warts: a randomised observer blind placebo controlled study","volume":"67","author":"Handley","year":"1991","journal-title":"Genitourin Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib62","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1258\/ijsa.2007.007196","article-title":"Comparison of cryotherapy to imiquimod 5% in the treatment of anogenital warts","volume":"19","author":"Stefanaki","year":"2008","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib63","first-page":"273","article-title":"Cryotherapy versus electrocautery in the treatment of genital warts","volume":"57","author":"Simmons","year":"1981","journal-title":"Br J Vener Dis"},{"key":"10.1016\/j.jaad.2010.12.049_bib64","first-page":"59","article-title":"Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment","volume":"61","author":"Duus","year":"1985","journal-title":"Genitourin Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib65","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/bjs.1800761027","article-title":"Podophyllin versus scissor excision in the treatment of perianal condylomata acuminata: a prospective study","volume":"76","author":"Khawaja","year":"1989","journal-title":"Br J Surg"},{"key":"10.1016\/j.jaad.2010.12.049_bib66","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(85)92677-7","article-title":"Comparison of podophyllin application with simple surgical excision in clearance and recurrence of perianal condylomata acuminata","volume":"2","author":"Jensen","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2010.12.049_bib67","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/00002030-200202150-00017","article-title":"Combined surgery and cidofovir is an effective treatment for genital warts in HIV-infected patients","volume":"16","author":"Orlando","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib68","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1001\/archderm.138.10.1303","article-title":"Viral disease transmitted by laser-generated plume (aerosol)","volume":"138","author":"Garden","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib69","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0190-9622(89)70146-8","article-title":"Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation: detection and protection","volume":"21","author":"Sawchuk","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib70","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jama.1988.03720080033024","article-title":"Papillomavirus in the vapor of carbon dioxide laser-treated verrucae","volume":"259","author":"Garden","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2010.12.049_bib71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/019459989110400206","article-title":"Polymerase chain reaction identification of human papillomavirus DNA in CO2 laser plume from recurrent respiratory papillomatosis","volume":"104","author":"Kashima","year":"1991","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaad.2010.12.049_bib72","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0190-9622(95)90065-9","article-title":"Risk of acquiring human papillomavirus from the plume produced by the carbon dioxide laser in the treatment of warts","volume":"32","author":"Gloster","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib73","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/BF01463570","article-title":"Laryngeal papillomatosis with human papillomavirus DNA contracted by a laser surgeon","volume":"248","author":"Hallmo","year":"1991","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaad.2010.12.049_bib74","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1378\/chest.99.3.557","article-title":"Cardiotoxicity of interferon. A review of 44 cases","volume":"99","author":"Sonnenblick","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.jaad.2010.12.049_bib75","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007890-198802000-00031","article-title":"Adverse effect of low-dose prophylactic human recombinant leukocyte interferon-alpha treatment in renal transplant recipients. Cytomegalovirus infection prophylaxis leading to an increased incidence of irreversible rejections","volume":"45","author":"Kovarik","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2010.12.049_bib76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-3542(94)90067-1","article-title":"Interferons in human papillomavirus infections","volume":"24","author":"Cirelli","year":"1994","journal-title":"Antiviral Res"},{"issue":"suppl 4","key":"10.1016\/j.jaad.2010.12.049_bib77","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.1111\/j.1600-6143.2009.02906.x","article-title":"Human papillomavirus infection in solid organ transplant recipients","volume":"9","author":"Kwak","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2010.12.049_bib78","first-page":"27","article-title":"Treatment of condylomata acuminata with pegylated interferon alfa-2b in HIV-infected patients","volume":"11","author":"Brockmeyer","year":"2006","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jaad.2010.12.049_bib79","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00007435-199808000-00007","article-title":"A randomized phase II study comparing four different interferon therapies in patients with recalcitrant condylomata acuminata","volume":"25","author":"Trizna","year":"1998","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2010.12.049_bib80","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(97)01037-1","article-title":"A randomized, double-blind trial of parenteral low dose versus high dose interferon-beta in combination with cryotherapy for treatment of condyloma acuminatum","volume":"35","author":"Bonnez","year":"1997","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jaad.2010.12.049_bib81","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1086\/322593","article-title":"Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection","volume":"33","author":"Snoeck","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2010.12.049_bib82","first-page":"523","article-title":"Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines","volume":"10","author":"Andrei","year":"1998","journal-title":"Oncol Res"},{"key":"10.1016\/j.jaad.2010.12.049_bib83","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/15257779908041563","article-title":"Antitumor potential of acyclic nucleoside phosphonates","volume":"18","author":"De Clercq","year":"1999","journal-title":"Nucleosides Nucleotides"},{"key":"10.1016\/j.jaad.2010.12.049_bib84","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0190-9622(98)70046-5","article-title":"Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects","volume":"39","author":"Zabawski","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib85","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1046\/j.1468-3083.2000.00184.x","article-title":"Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV\/AIDS. A pilot study","volume":"14","author":"Calista","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.12.049_bib86","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/14656560902960154","article-title":"Cidofovir: clinical experience and future perspectives on an acyclic nucleoside phosphonate analog of cytosine in the treatment of refractory and premalignant HPV-associated anal lesions","volume":"10","author":"Coremans","year":"2009","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jaad.2010.12.049_bib87","unstructured":"Douglas J, Corey T, Tyring S, Kreisel J, Bowden B, Crosby D, et\u00a0al. A phase I\/II study of cidofovir topical gel for refractory condyloma acuminatum in patients with HIV infection. Presented in poster form at the 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 22-26, 1997: poster 334."},{"key":"10.1016\/j.jaad.2010.12.049_bib88","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00007435-200106000-00007","article-title":"Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons","volume":"28","author":"Matteelli","year":"2001","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.jaad.2010.12.049_bib89","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJM199510053331418","article-title":"Treatment of anogenital papillomavirus infections with an acyclic nucleoside phosphonate analogue","volume":"333","author":"Snoeck","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib90","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1097\/00002030-199910010-00023","article-title":"Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients","volume":"13","author":"Orlando","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib91","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1046\/j.1468-3083.2001.00288.x","article-title":"Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection","volume":"15","author":"Martinelli","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.12.049_bib92","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jmv.2213","article-title":"Local treatment of HPV-induced skin lesions by cidofovir","volume":"67","author":"Stragier","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.jaad.2010.12.049_bib93","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/sti.76.2.143","article-title":"Successful treatment of recalcitrant condyloma with topical cidofovir","volume":"76","author":"Hengge","year":"2000","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jaad.2010.12.049_bib94","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0190-9622(03)00870-3","article-title":"Topical cidofovir for condylomata acuminata of the genitalia in a 3-year-old child","volume":"49","author":"Calisto","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib95","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00007890-200202270-00033","article-title":"Topical use of cidofovir induced acute renal failure","volume":"73","author":"Bienvenu","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jaad.2010.12.049_bib96","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/GRF.0b013e31818092a3","article-title":"New approaches to external genital warts and vulvar intraepithelial neoplasia","volume":"51","author":"Kennedy","year":"2008","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.jaad.2010.12.049_bib97","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/sti.2009.038075","article-title":"A multicentre, randomised, double-blind, placebo controlled study of cryotherapy versus cryotherapy and podophyllotoxin cream as treatment for external anogenital warts","volume":"85","author":"Gilson","year":"2009","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jaad.2010.12.049_bib98","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s10350-004-7287-5","article-title":"Topical cidofovir (HPMPC) is an effective adjuvant to surgical treatment of anogenital condylomata acuminata","volume":"46","author":"Coremans","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaad.2010.12.049_bib99","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1258\/0956462011924407","article-title":"Factors involved in clearance of genital warts","volume":"12","author":"Wilson","year":"2001","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib100","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/00016340701415038","article-title":"Human papillomavirus-type predict the clinical outcome of imiquimod therapy for women with vulvar condylomata acuminata","volume":"86","author":"Dede","year":"2007","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jaad.2010.12.049_bib101","first-page":"377","article-title":"Detection of HPV in genital condylomata: correlation between viral load and clinical outcome","volume":"20","author":"De Marco","year":"2001","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jaad.2010.12.049_bib102","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1258\/0956462054944390","article-title":"Correlation between deoxyribonucleic acid loads of human papillomavirus and recurrence of condylomata acuminata","volume":"16","author":"Che","year":"2005","journal-title":"Int J STD AIDS"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2010.12.049_bib103","first-page":"S1","article-title":"The epidemiology of genital human papillomavirus infection","volume":"24","author":"Trottier","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jaad.2010.12.049_bib104","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(00)04956-4","article-title":"Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study","volume":"357","author":"Woodman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2010.12.049_bib105","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/sti.2007.025478","article-title":"Frequently asked questions about genital warts in the genitourinary medicine clinic: an update and review of recent literature","volume":"84","author":"Goon","year":"2008","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jaad.2010.12.049_bib106","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.det.2006.01.009","article-title":"Human papillomaviruses and genital disease","volume":"24","author":"Ahmed","year":"2006","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2010.12.049_bib107","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1128\/JCM.37.7.2270-2273.1999","article-title":"Detection of human papillomavirus types 6 and 11 in pubic and perianal hair from patients with genital warts","volume":"37","author":"Boxman","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jaad.2010.12.049_bib108","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1007\/BF02234473","article-title":"Giant condyloma acuminatum of the anorectum: trends in epidemiology and management: report of a case and review of the literature","volume":"44","author":"Trombetta","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaad.2010.12.049_bib109","first-page":"324","article-title":"Radical excision and mesh-skin grafting for giant anorectal condyloma acuminatum","volume":"32","author":"Chaidemenos","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.12.049_bib110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02554502","article-title":"Malignant transformation of anorectal giant condyloma acuminatum (Buschke\u2013Lowenstein tumor)","volume":"32","author":"Creasman","year":"1989","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaad.2010.12.049_bib111","first-page":"98","article-title":"HPV-related anogenital disease and HIV infection: not always \u2018ordinary\u2019 condylomata acuminata","volume":"66","author":"Mudrikova","year":"2008","journal-title":"Neth J Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib112","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/BF02052606","article-title":"Giant condyloma acuminatum (Buschke\u2013Lowenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases","volume":"37","author":"Chu","year":"1994","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaad.2010.12.049_bib113","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1097\/00002030-200405210-00022","article-title":"Buschke\u2013Lowenstein lesion: another possible manifestation of immune restoration inflammatory syndrome?","volume":"18","author":"Moussa","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib114","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000094979","article-title":"Surgical management of perianal giant condyloma acuminatum (Buschke\u2013Lowenstein tumor). Report of three cases","volume":"38","author":"De Toma","year":"2006","journal-title":"Eur Surg Res"},{"key":"10.1016\/j.jaad.2010.12.049_bib115","first-page":"487","article-title":"Vulvar neoplasia in HIV positive women: a review","volume":"7","author":"Casolati","year":"2003","journal-title":"Med Wieku Rozwoj"},{"key":"10.1016\/j.jaad.2010.12.049_bib116","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1089\/apc.1998.12.251","article-title":"Vulvar intraepithelial neoplasia in women with HIV","volume":"12","author":"Abercrombie","year":"1998","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib117","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.critrevonc.2008.02.012","article-title":"Review of squamous premalignant vulvar lesions","volume":"68","author":"van de Nieuwenhof","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jaad.2010.12.049_bib118","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa072685","article-title":"Treatment of vulvar intraepithelial neoplasia with topical imiquimod","volume":"358","author":"van Seters","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2010.12.049_bib119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00001703-199901000-00007","article-title":"Human immunodeficiency virus infection and female lower genital tract malignancy","volume":"11","author":"Kuhn","year":"1999","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.jaad.2010.12.049_bib120","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/sj.bjc.6601219","article-title":"Cancer risk following organ transplantation: a nationwide cohort study in Sweden","volume":"89","author":"Adami","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2010.12.049_bib121","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ijc.2910600209","article-title":"Cancer risk after renal transplantation in the Nordic countries, 1964-1986","volume":"60","author":"Birkeland","year":"1995","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jaad.2010.12.049_bib122","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/01.AOG.0000210237.80211.ff","article-title":"Vulvar, vaginal, and perianal intraepithelial neoplasia in women with or at risk for human immunodeficiency virus","volume":"107","author":"Jamieson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jaad.2010.12.049_bib123","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaad.2005.05.007","article-title":"Penile cancer","volume":"54","author":"Micali","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib124","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/archdermatol.2009.160","article-title":"Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy","volume":"145","author":"Eliason","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000176016","article-title":"Chemotherapy in patients with penile carcinoma","volume":"82","author":"Protzel","year":"2009","journal-title":"Urol Int"},{"key":"10.1016\/j.jaad.2010.12.049_bib126","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1089\/apc.2006.0059","article-title":"An extensive case of Bowen\u2019s disease in an HIV-positive male","volume":"21","author":"Schmitz","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib127","first-page":"278","article-title":"Bowenoid papulosis in a patient with AIDS treated with imiquimod: case report","volume":"12","author":"Nunes Mde","year":"2004","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaad.2010.12.049_bib128","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1258\/0956462042563774","article-title":"A case of Bowenoid papulosis of the penis successfully treated with topical imiquimod cream 5%","volume":"15","author":"Goorney","year":"2004","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.jaad.2010.12.049_bib129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1067\/mjd.2001.119103","article-title":"Topical imiquimod 5% cream in the treatment of Bowen\u2019s disease of the penis","volume":"46","author":"Cook-Bolden","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib130","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jaad.2006.07.021","article-title":"Erythroplasia of Queyrat treated with imiquimod 5% cream","volume":"55","author":"Micali","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2010.12.049_bib131","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1046\/j.1365-2230.28.s1.2.x","article-title":"Topical treatment of intraepithelial penile carcinoma with imiquimod","volume":"28","author":"Micali","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib132","first-page":"483","article-title":"Bowen\u2019s disease of the penis treated with topical imiquimod 5% cream","volume":"7","author":"Taliaferro","year":"2008","journal-title":"J Drugs Dermatol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2010.12.049_bib133","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1046\/j.1365-2230.28.s1.3.x","article-title":"Treatment of Bowen\u2019s disease of the penis with imiquimod 5% cream","volume":"28","author":"Danielsen","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib134","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1067\/mjd.2002.120584","article-title":"Treatment of Bowen\u2019s disease of the penis with imiquimod","volume":"46","author":"Thai","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib135","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1067\/mjd.2002.120444","article-title":"Squamous cell carcinoma in situ of the penis successfully treated with imiquimod 5% cream","volume":"46","author":"Schroeder","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib136","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000063140","article-title":"Imiquimod 5% cream in the treatment of human papillomavirus-16-positive erythroplasia of Queyrat","volume":"205","author":"Kaspari","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.12.049_bib137","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11904-008-0013-5","article-title":"Human papillomavirus and anal neoplasia","volume":"5","author":"Palefsky","year":"2008","journal-title":"Curr HIV\/AIDS Rep"},{"key":"10.1016\/j.jaad.2010.12.049_bib138","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10350-007-9154-7","article-title":"Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy","volume":"51","author":"Wexler","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaad.2010.12.049_bib139","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/bjs.4967","article-title":"Anal intraepithelial neoplasia","volume":"92","author":"Abbasakoor","year":"2005","journal-title":"Br J Surg"},{"key":"10.1016\/j.jaad.2010.12.049_bib140","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1086\/344057","article-title":"Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus","volume":"35","author":"Chin-Hong","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaad.2010.12.049_bib141","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1046\/j.1365-2133.2002.04729.x","article-title":"Successful treatment of anogenital Bowen\u2019s disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry","volume":"147","author":"Gutzmer","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib142","first-page":"3031","article-title":"Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%","volume":"7","author":"Diaz-Arrastia","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jaad.2010.12.049_bib143","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1001\/archderm.137.1.14","article-title":"Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in\u00a0situ in an HIV-1-positive man","volume":"137","author":"Pehoushek","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib144","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jaad.2003.12.025","article-title":"Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream","volume":"50","author":"Kreuter","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib145","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2133.2007.08004.x","article-title":"p16ink4a expression decreases during imiquimod treatment of anal intraepithelial neoplasia in human immunodeficiency virus-infected men and correlates with the decline of lesional high-risk human papillomavirus DNA load","volume":"157","author":"Kreuter","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.12.049_bib146","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/archderm.142.11.1438","article-title":"Imiquimod treatment of anal intraepithelial neoplasia in HIV-positive men","volume":"142","author":"Wieland","year":"2006","journal-title":"Arch Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211008139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211008139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:23:48Z","timestamp":1759271028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962211008139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":146,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0190962211008139"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.12.049","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human papillomavirus\u2013related genital disease in the immunocompromised host","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.12.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}